Hypoglycemia  >>  Symlin (pramlintide)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symlin (pramlintide) / AstraZeneca
NCT03547427: Glucagon Counterregulation in Type 1 Diabetes

Terminated
N/A
13
US
Basal insulin alone, Basal pramlintide and reduced basal insulin, CGM, Acetaminophen test, Insulin-induced hypoglycemia, Exercise-induced hypoglycemia
University of Virginia
Type 1 Diabetes Mellitus
03/19
03/19
NCT03993366: Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement

Completed
N/A
8
Canada
Fiasp+Pramlintide Closed-Loop System, Fiasp Closed-Loop System
McGill University, Juvenile Diabetes Research Foundation
Type 1 Diabetes Mellitus
08/19
08/19

Download Options